Pregnancy-associated plasma protein-A and the vulnerable plaque

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Pregnancy-associated plasma protein-A and the vulnerable plaque. / Jespersen, Camilla H B; Vestergaard, Kirstine R; Schou, Morten; Teisner, Børge; Goetze, Jens P; Iversen, Kasper.

I: Biomarkers in Medicine, Bind 8, Nr. 8, 2014, s. 1033-47.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Jespersen, CHB, Vestergaard, KR, Schou, M, Teisner, B, Goetze, JP & Iversen, K 2014, 'Pregnancy-associated plasma protein-A and the vulnerable plaque', Biomarkers in Medicine, bind 8, nr. 8, s. 1033-47. https://doi.org/10.2217/bmm.14.53

APA

Jespersen, C. H. B., Vestergaard, K. R., Schou, M., Teisner, B., Goetze, J. P., & Iversen, K. (2014). Pregnancy-associated plasma protein-A and the vulnerable plaque. Biomarkers in Medicine, 8(8), 1033-47. https://doi.org/10.2217/bmm.14.53

Vancouver

Jespersen CHB, Vestergaard KR, Schou M, Teisner B, Goetze JP, Iversen K. Pregnancy-associated plasma protein-A and the vulnerable plaque. Biomarkers in Medicine. 2014;8(8):1033-47. https://doi.org/10.2217/bmm.14.53

Author

Jespersen, Camilla H B ; Vestergaard, Kirstine R ; Schou, Morten ; Teisner, Børge ; Goetze, Jens P ; Iversen, Kasper. / Pregnancy-associated plasma protein-A and the vulnerable plaque. I: Biomarkers in Medicine. 2014 ; Bind 8, Nr. 8. s. 1033-47.

Bibtex

@article{85eccefc3f5f42ea9ce70c14925f848d,
title = "Pregnancy-associated plasma protein-A and the vulnerable plaque",
abstract = "For more than a decade, pregnancy-associated plasma protein-A (PAPP-A) has been examined for its relation to acute coronary syndrome (ACS) and the vulnerable plaque. This review summarizes the current knowledge of plasma PAPP-A in relation to nonpregnant individuals focusing on patients with ACS, discusses its use as a possible biomarker for diagnosis and prognosis in ACS, briefly describes the challenges in different assay technologies and describes the effect of heparin administration on PAPP-A concentrations in plasma.",
author = "Jespersen, {Camilla H B} and Vestergaard, {Kirstine R} and Morten Schou and B{\o}rge Teisner and Goetze, {Jens P} and Kasper Iversen",
year = "2014",
doi = "10.2217/bmm.14.53",
language = "English",
volume = "8",
pages = "1033--47",
journal = "Biomarkers in Medicine",
issn = "1752-0363",
publisher = "Future Medicine Ltd.",
number = "8",

}

RIS

TY - JOUR

T1 - Pregnancy-associated plasma protein-A and the vulnerable plaque

AU - Jespersen, Camilla H B

AU - Vestergaard, Kirstine R

AU - Schou, Morten

AU - Teisner, Børge

AU - Goetze, Jens P

AU - Iversen, Kasper

PY - 2014

Y1 - 2014

N2 - For more than a decade, pregnancy-associated plasma protein-A (PAPP-A) has been examined for its relation to acute coronary syndrome (ACS) and the vulnerable plaque. This review summarizes the current knowledge of plasma PAPP-A in relation to nonpregnant individuals focusing on patients with ACS, discusses its use as a possible biomarker for diagnosis and prognosis in ACS, briefly describes the challenges in different assay technologies and describes the effect of heparin administration on PAPP-A concentrations in plasma.

AB - For more than a decade, pregnancy-associated plasma protein-A (PAPP-A) has been examined for its relation to acute coronary syndrome (ACS) and the vulnerable plaque. This review summarizes the current knowledge of plasma PAPP-A in relation to nonpregnant individuals focusing on patients with ACS, discusses its use as a possible biomarker for diagnosis and prognosis in ACS, briefly describes the challenges in different assay technologies and describes the effect of heparin administration on PAPP-A concentrations in plasma.

U2 - 10.2217/bmm.14.53

DO - 10.2217/bmm.14.53

M3 - Journal article

C2 - 25343675

VL - 8

SP - 1033

EP - 1047

JO - Biomarkers in Medicine

JF - Biomarkers in Medicine

SN - 1752-0363

IS - 8

ER -

ID: 137315003